Low-dose naltrexone for treatment of multiple sclerosis: clinical trials are needed

Ann Pharmacother. 2007 Sep;41(9):1549-50. doi: 10.1345/aph.1H083. Epub 2007 Jul 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Naltrexone / therapeutic use*
  • Narcotic Antagonists / therapeutic use

Substances

  • Narcotic Antagonists
  • Naltrexone